Abstract. The purpose of this study was to evaluate the effects of the thickness and depth of tumors on hemoglobin measurements in breast cancer by optical spectroscopy and to demonstrate tissue oxygen saturation (SO 2 ) and reduced scattering coefficient (μ 0 s ) in breast tissue and breast cancer in relation to the skin-tochest wall distance. We examined 53 tumors from 44 patients. Total hemoglobin concentration (tHb), SO 2 , and μ 0 s were measured by time-resolved spectroscopy (TRS). The skin-to-chest wall distance and the size and depth of tumors were measured by ultrasonography. There was a positive correlation between tHb and tumor thickness, and a negative correlation between tHb and tumor depth. SO 2 in breast tissue decreased when the skin-to-chest wall distance decreased, and SO 2 in tumors tended to be lower than in breast tissue. In breast tissue, there was a negative correlation between μ 0 s and the skin-to-chest wall distance, and μ 0 s in tumors was higher than in breast tissue. Measurement of tHb in breast cancer by TRS was influenced by tumor thickness and depth. Although SO 2 seemed lower and μ 0 s was higher in breast cancer than in breast tissue, the skin-to-chest wall distance may have affected the measurements.
Factors affecting measurement of optic parameters by time-resolved near-infrared spectroscopy in breast cancer Nobuko Diffuse optical spectroscopy with near-infrared light can assess tumor angiogenesis based on tissue hemoglobin concentrations. The concentrations of oxygenated and deoxygenated hemoglobin can be calculated from the absorption coefficient at multiple wavelengths. As optical spectroscopy is not expensive and can be repeated without ionizing radiation, this technique is promising for assessment of the effects of neoadjuvant chemotherapy for breast cancer. 1, 2 In the measurement of the absorption coefficient of breast cancer by optical spectroscopy, the surrounding mammary glands and fat are inevitably included in the measurement. Furthermore, chest wall muscles may be included when the skin-to-chest wall distance is small. We have demonstrated that hemoglobin measurement in breast cancer by time-resolved spectroscopy (TRS) was influenced by the chest wall muscles. 3 Tumor size and depth may also affect the measurement because the path length of light in the tumor and relative amount of light that reaches the tumor are different among tumors depending on their size and depth.
Although changes in tissue oxygen saturation (SO 2 ) may indicate the effectiveness of chemotherapy, 4, 5 there is no consensus on the SO 2 level in breast cancer. The reduced scattering coefficient (μ 0 s ) is another optical parameter that provides information on tissue structure and composition. 6 However, these indices may depend on the skin-to-chest wall distance.
The purpose of this study was to evaluate the effects of tumor size and depth on hemoglobin measurement in breast cancer and to report SO 2 and μ 0 s in breast tissue and in breast cancer in relation with the skin-to-chest wall distance.
Materials and Methods

Near-Infrared Time-Resolved Spectroscopy
Optical properties of normal breast tissue and cancer were measured using a single-channel near-infrared TRS system (TRS-20SH, Hamamatsu Photonics K.K., Hamamatsu, Japan). This system uses a time-correlated single-photon counting method for acquiring the temporal response profiles from the tissue against optical impulse inputs and enables quantitative analysis of light absorption and scattering in tissue by the photon diffusion theory. 7 An ultrashort pulsed laser light source (PLP, Hamamatsu Photonics K.K.) emits light pulses at three different wavelengths (758, 795, and 833 nm) with an average power of 200 μW, full width at half maximum (FWHM) of <100 picoseconds (ps), and repetition frequency of 5 MHz. The detector section of this system consisted of a photomultiplier tube (H7422P-50MOD, Hamamatsu Photonics K.K.) followed by constant fraction discriminators, time-to-amplitude converters, A/D converters, and histogram memories. The instrumental response function of the system was approximately 320-ps FWHM. The three light sources emitted a pulse on a time series, and the three-wavelength optical pulses were guided into one optical fiber via a fiber coupler (NTT Advanced Technology Corp., Kawasaki, Japan). Each single optical fiber (GC200/250L, Fujikura Ltd., Tokyo, Japan) used for light irradiation had a numerical aperture (NA) of 0.25 and a core diameter of 200 μm. The optical bundle fiber (SCHOTT MORITEX Corp., Asaka, Japan) used to collect the light had an NA of 0.26 and a bundle diameter of 3 mm. The nonlinear least-squares method was used to fit the solution of the time-domain photon diffusion equation with a semiinfinite homogeneous model to the observed temporal profiles. The zero boundary condition of the reflectance mode was employed. The time resolution of the temporal profile was 10 ps, and the data acquisition time was 3 s. The distance from the light source to the detector was 3 cm. The absorption coefficient and reduced scattering coefficient were obtained at each wavelength. The data over the time range from −560 to 5440 ps were selected for fitting. The reduced chi-square value was used to evaluate fitting accuracy. Our fitting process was successfully implemented if this value was within the range of 0.8 to 1.2. 8 The concentrations of oxygenated and deoxygenated hemoglobin were calculated from the absorption coefficient at each wavelength by the least-squares method after subtracting water and lipid absorption in breast tissue. We assumed that water content was 18.7% and lipid content was 66.1%. 9 The concentration of tHb was the sum of the concentrations of oxygenated hemoglobin and deoxygenated hemoglobin.
Ultrasonography
An ultrasonography (US) system (EUB-7500, Hitachi Medical Corporation, Tokyo, Japan) with a linear probe (EUP-L65, Hitachi Medical Corporation) was used. The probe had a frequency range of 6 to 14 MHz. A spectroscopic probe was attached to the US probe. 3 
Patient Characteristics
We examined 86 patients with breast lesions between June 2013 and April 2016. We excluded 32 patients who had undergone chemotherapy or hormonal therapy. Three patients in whom the final diagnosis was not cancer were excluded. We excluded two patients just after biopsy and two patients just after subcutaneous injection of a radiopharmaceutical around the tumor for sentinel lymph node biopsy. We also excluded two patients whose tumors were undetectable on US and one patient in whom ultrasound images were not recorded. Finally, 44 patients were included in this study. All patients were female and their median age was 52.3 years, with a range of 33 to 78 years. Twenty patients were premenopausal and 24 patients were postmenopausal. The patients underwent TRS and US scan at least 12 days after core needle biopsy. Six patients had multiple lesions, and a total of 53 lesions were evaluated. Forty tumors were found to be invasive ductal cancer, 12 tumors were ductal carcinoma in situ, and one tumor was invasive lobular carcinoma. The mean maximum transverse diameter of the tumors was 19.5 mm, with a range of 7 to 61 mm. The study protocol was approved by the Ethical Review Committee of Hamamatsu University School of Medicine. All patients signed a written informed consent form.
TRS and US Scan Protocol
After the spectroscopic probe that was attached to the US probe was placed on the skin just above the tumor, the absorption coefficient and reduced scattering coefficient at three wavelengths were measured simultaneously. Tumor thickness, depth, and skin-to-chest wall distance were measured by US. The distance from the skin to the anterior surface of the tumor was defined as the depth. The distance between the anterior and posterior surface of the tumor was defined as the thickness. The chest wall was defined as the surface of the major pectoral muscle or anterior serratus muscle. The default setting of the maximal depth in our US system was 36 mm, and we were not able to measure the skin-to-chest wall distance in two normal breasts and four tumor-containing breasts. They were excluded from the analysis using the correlation coefficient between optical parameters and the skin-to-chest wall distance.
The optical parameters of normal breast tissue were measured in the contralateral breast at the corresponding area. Although the number of tumors examined was 53, the number from normal breasts was 46. The number of the measurement points in the normal side was less than the number of tumors in the patients who had multiple lesions.
Net tHb (tHb net ) was defined as the difference between tumor tHb and tHb in normal breast tissue (Fig. 1) . The reference curve of the tHb concentration in normal breast tissue as a function of the skin-to-chest wall distance for pre-and postmenopausal patients was derived from the previous study. 3 
Statistical Analysis
Statistical examinations were performed using Microsoft Excel 2013 (Microsoft Corporation, Redmond, Washington) and StatFlex version 6.0 (Artech Co., Ltd., Osaka, Japan).
The Pearson's correlation coefficient was calculated to compare the relationship between tHb and tumor thickness, tHb net and tumor thickness, tHb and tumor depth, tHb net and tumor depth, tumor depth and skin-to-chest wall distance, SO 2 and the skin-to-chest wall distance, μ 0 s and body mass index (BMI), and μ 0 s and the skin-to-chest wall distance. Linear regression analyses were carried out for each pairing. The differences in SO 2 and μ 0 s between tumor and normal breast tissues were determined using nonparametric Mann-Whitney U tests. Differences with P < 0.05 were considered significant. depth was small in tumors with a small skin-to-chest wall distance [ Fig. 4(c) ].
Tissue Oxygen Saturation
SO 2 in normal breast tissue decreased when the skin-to-chest wall distance decreased [ Fig. 5(a) ]. The mean SO 2 in normal breast tissue was 78.1% AE 2.9% (mean AE SD). To minimize the effects of the chest wall, SO 2 in breast with a skin-tochest wall distance larger than 21 mm was analyzed. The tumor SO 2 was lower than normal breast tissue SO 2 , although the difference was not significant [ Fig. 5(b) ].
Reduced Scattering Coefficient
We reported results on μ 0 s at a wavelength of 795 nm (μ 0 s795 ). In normal breast tissue, a negative correlation was found between μ 0 s795 and BMI [ Fig. 6(a) ]. A negative correlation was also found between μ 0 s795 and age (data not shown). There was a negative correlation between μ 0 s795 and the skin-to-chest wall distance [ Fig. 6(b) ]. The μ 0 s795 in tumors was higher than that in normal breast tissue when the skin-to-chest wall distance was larger than 21 mm [ Fig. 6(c) ].
Discussion
The tHb was higher in patients with thick tumors when the skinto-chest wall distance was larger than 21 mm. As the length of the light path through tumors was long in thick tumors, the tHb measurement was likely to be high. In a previous study, we proposed a subtraction method to assess the hemoglobin concentration, in which the skin-to-chest wall distance was taken into consideration. 3 There was a positive correlation between the tHb net and tumor thickness for all tumors, including patients with a small skin-to-chest wall distance, suggesting that tHb net is a good indicator of tHb for tumors irrespective of the skin-tochest wall distance.
In measurements with a reflection-type probe, the detection sensitivity of the optical measurement had a limit in the depth direction. 10 When the tumor was located deep in the breast, tHb measurements were low because of low sensitivity. tHb demonstrated a stronger correlation with tumor depth than tHb net . In tumors where the skin-to-chest wall distance was small, the tumor was located near the skin [ Fig. 4(c) ]. In such situations, tHb measurements may be artificially high, which caused a stronger correlation of tHb with tumor depth.
The usefulness of tHb net is under investigation in clinical settings. We assessed the therapeutic response to neoadjuvant chemotherapy for breast cancer by spectroscopy and found that tHb net reflected therapeutic response more precisely than tHb.
SO 2 tended to be lower in breast cancer than in normal breast tissue when the skin-to-chest wall distance was larger than 21 mm, although the difference was not significant. There has been controversy over SO 2 in breast cancer. Chance et al. 11 reported that SO 2 in cancer was lower, whereas Grosenick et al. 12 and Choe et al. 13 reported that SO 2 in cancer was not lower than that in normal breast tissue. SO 2 in breast tissue decreased when the skin-to-chest wall distance was small [ Fig. 5(a) ]. SO 2 in the antebrachial muscle measured by TRS was reported as 73.9% AE 2.8% (mean AE SD).
14 SO 2 in normal breast tissue measured in this study was 78.1% AE 2.9% (mean AE SD), and SO 2 can be affected by chest wall muscles. The μ 0 s in normal breast tissue was low in patients with high BMI and in older patients, which is in accordance with the results of previous studies. 15, 16 Adipose tissue has a lower μ 0 s than glandular tissue. 17 A low μ 0 s may reflect high amounts of fat in older patients and in patients with a high BMI. The μ 0 s in normal breast tissue increased when the skin-to-chest wall distance decreased, and the μ 0 s in muscles is reported to be widely distributed. 18 The μ 0 s in muscles can be higher than in mammary glands and the measurement of μ 0 s in breast tissue may also be influenced by chest wall muscles. It was reported that the μ 0 s was high in tumors compared with that in normal breast tissue. 12, 13, 19 In this study, the μ 0 s was higher in tumors than in normal breast tissue when the skin-to-chest wall distance was larger than 21 mm.
In conclusion, tumor thickness and depth, in addition to chest wall muscles, influenced measurement of tHb by TRS in breast cancer. Our proposed indicator, tHb net , reflected the influence of tumor thickness and depth accurately, suggesting it as a good indicator of tHb irrespective of the skin-to-chest wall distance. The measurement of SO 2 and μ 0 s was also affected by the chest wall. The effects of the chest wall on the measurement of optical properties by TRS should be considered.
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